<https://rdf.molmedb.upol.cz/reference/ref2357> <http://purl.org/dc/terms/subject> <https://identifiers.org/molmedb/MM471255>;
	<http://purl.org/ontology/bibo/doi> "10.1016/j.bmc.2011.12.013"^^<http://www.w3.org/2001/XMLSchema#string>;
	<http://purl.org/dc/terms/subject> <https://rdf.molmedb.upol.cz/interaction/membrane19>,
		<https://identifiers.org/molmedb/MM496202>;
	<http://purl.org/ontology/bibo/pmid> "22249122"^^<http://www.w3.org/2001/XMLSchema#string>;
	<http://purl.org/dc/terms/subject> <https://identifiers.org/molmedb/MM471253>;
	<http://purl.org/dc/terms/bibliographicCitation> "Fabio K, Guillon C, Lacey CJ, Lu SF, Heindel ND, Ferris CF, Placzek M, Jones G, Brownstein MJ, Simon NG.: Synthesis and evaluation of potent and selective human V1a receptor antagonists as potential ligands for PET or SPECT imaging. Bioorg Med Chem, Volume 20 (3), 2012"^^<http://www.w3.org/2001/XMLSchema#string>;
	<http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://purl.org/dc/terms/BibliographicResource>;
	<http://purl.org/dc/terms/subject> <https://rdf.molmedb.upol.cz/interaction/method30>,
		<https://identifiers.org/molmedb/MM496202.1> .
<https://rdf.molmedb.upol.cz/interaction/int962091> <http://www.w3.org/ns/prov#hadPrimarySource> <https://rdf.molmedb.upol.cz/reference/ref2357> .
<https://rdf.molmedb.upol.cz/interaction/int1019496> <http://www.w3.org/ns/prov#hadPrimarySource> <https://rdf.molmedb.upol.cz/reference/ref2357> .
<https://rdf.molmedb.upol.cz/interaction/int962090> <http://www.w3.org/ns/prov#hadPrimarySource> <https://rdf.molmedb.upol.cz/reference/ref2357> .
<https://rdf.molmedb.upol.cz/interaction/int962089> <http://www.w3.org/ns/prov#hadPrimarySource> <https://rdf.molmedb.upol.cz/reference/ref2357> .
<https://rdf.molmedb.upol.cz/interaction/int1019494> <http://www.w3.org/ns/prov#hadPrimarySource> <https://rdf.molmedb.upol.cz/reference/ref2357> .